Ongoing clinical studies

  • CANNABINOIDS studies

    Duration: 5 visits spaced at least one week
    Recruitment:Ongoing, ending December 30th 2022
    Age: 21 to 65 years old

    Participants wanted:

    Have used cannabis at least once in their life, be in good health, willing to use the research product during the study.

    read study
  • HEPCO Study

    Duration: visits every three months (90 min) for an unlimited period
    Age:18 years and over

    Participants wanted:

    Men and women consuming injection drugs (in the last 6 months)

    read study
    seringue fond vert
  • ECHO Study

    Duration: 24 months
    Recruitment:In progress
    Age:18 years and over

    Participants wanted:

    Quebec health and social services professionals and clinicians who are enrolled in the ECHO®CHUM concurrent disorders training program.

    read study

Completed clinical studies

Future studies
  • JANUARY 2021 : E-mental health for young adults with psychosis: a web-based psychosocial intervention to treat cannabis use disorder.
  • JANUARY 2021 : CHAMPS: a proof-of-concept and feasibility trial of a cannabis harm reduction intervention for young adults with psychosis (CHAMPS Trial)

CHUM Research Center (CRCHUM)

900 St-Denis St., 4th & 5th floor,

Montreal (QC) H2X0A9

Phone: 514-890-8000 #30933

Myths and realities of a clinical research study

Didier Jutras-Aswad

©all rights reserved, Web creation TLA Graff 

Thank you to the funding agencies

*People wishing to participate in one of the studies or who have questions about them can contact the lab. People who wish to obtain addiction and/or mental health care or services can contact the addiction rehabilitation center or the psychosocial center in their region. They can also call emergency services if their condition requires it.